Colin Hill is a leading voice in machine learning in healthcare and precision medicine. He co-founded GNS Healthcare in 2000 and has since served as Chairman & CEO. Colin sits on board of Biotelemetry Inc. (NASDAQ: BEAT), the leading mobile health information company, and PPD, a leading global contract research organization. Colin was a founding member of the Board of Directors of AesRx, (acquired by Baxter in 2014). In 2004, Colin was named to MIT Technology Review’s TR100 list of the top 100 innovators in the world under the age of 35.